Alphatec Spine Reports 1Q19 Revenue of $24.6MM, +15.3% vs. 1Q18

Alphatec Spine reports 1Q19 revenue of USD $24.6MM, +15.3% vs. 1Q18.

• Continued to update legacy-heavy portfolio with three new releases: the IdentiTi ACDF, the IdentiTi PLIF system and AlphaGRAFT DBM Fiber
• Received FDA clearance for SafeOP neuromonitoring system
• New products contributed 22% of U.S. revenue for the quarter
• Sales from strategic distributors comprised 84% of U.S. revenue for the quarter, up from 72% the prior year
• Compared to 1Q18, revenue per distributor increased 30% and revenue per case increased 13%
• Non-strategic international supply agreements are winding down, per leadership

Segment sales and growth on an as-reported basis ($MM):

Revenue by geographic region ($MM):

Net earnings ($MM):

Sources: Alphatec Spine; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.